Personal tools

MCL coexpression mm9:71: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162000848159969,0,0,0,0,0,0,0,0,0.106546909924599,0.742511321356281,0.855728928727289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.519619002084919,0.833320499249606,0.670161252121747,0.6131735875786,0.472711233097333,0,0,0,0,0,0,0,0,0,0,0,0.291073584836546,0,0,0,0.0824580172145032,0.218821008874332,0.370817093646227,0.241516871244163,0.311122885272949,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.280332823170933,0,0,0,0,0,0,0.215665353490502,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0945084131504676,0,0.073294297058821,0.10954190162672,0.081359932135904,0.120876255993453,0.0978461107777356,0.098117166361508,0.0750453505157095,0.138165606837579,0.0990244263857601,0.0898139621139603,0.169172763866184,0.0905291472420136,0.0766073954291401,0.14986111676545,0.112067779638927,0.128033729919821,0.131923786075207,0.092873634605593,0.110822898586572,0.10799917315244,0.126604887871452,0.135404897539632,0.101427320830301,0.147135556490426,0,0.0924644954689594,0.112441925220423,0.148982201447044,0.117229416500102,0.40538954630897,0.351999668610516,0.380860325368858,0.35968873130767,0.246782435917445,0.220572027003917,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.162000848159969,0,0,0,0,0,0,0,0,0.106546909924599,0.742511321356281,0.855728928727289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.519619002084919,0.833320499249606,0.670161252121747,0.6131735875786,0.472711233097333,0,0,0,0,0,0,0,0,0,0,0,0.291073584836546,0,0,0,0.0824580172145032,0.218821008874332,0.370817093646227,0.241516871244163,0.311122885272949,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.280332823170933,0,0,0,0,0,0,0.215665353490502,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0945084131504676,0,0.073294297058821,0.10954190162672,0.081359932135904,0.120876255993453,0.0978461107777356,0.098117166361508,0.0750453505157095,0.138165606837579,0.0990244263857601,0.0898139621139603,0.169172763866184,0.0905291472420136,0.0766073954291401,0.14986111676545,0.112067779638927,0.128033729919821,0.131923786075207,0.092873634605593,0.110822898586572,0.10799917315244,0.126604887871452,0.135404897539632,0.101427320830301,0.147135556490426,0,0.0924644954689594,0.112441925220423,0.148982201447044,0.117229416500102,0.40538954630897,0.351999668610516,0.380860325368858,0.35968873130767,0.246782435917445,0.220572027003917,0
|gostat_on_MCL_coexpression=GO:0016042;lipid catabolic process;0.0029286779344968;240633,18784,271844,78753,26971!GO:0004623;phospholipase A2 activity;0.00530930889302839;18784,271844,26971!GO:0016787;hydrolase activity;0.0176780471448425;18784,271844,230598,77042,23993,26971,24000,240633,224079,16622,78753,104184,12365,13648,243083!GO:0004175;endopeptidase activity;0.018306204847719;16622,230598,23993,104184,13648,12365,243083!GO:0006629;lipid metabolic process;0.018306204847719;18784,271844,18705,26971,14081,240633,78753,107605!GO:0004620;phospholipase activity;0.018306204847719;18784,271844,26971!GO:0006508;proteolysis;0.018306204847719;116872,16622,230598,23993,104184,13648,12365,243083!GO:0006644;phospholipid metabolic process;0.018306204847719;18784,271844,18705,26971!GO:0004293;tissue kallikrein activity;0.0290738219152611;16622,13648!GO:0004866;endopeptidase inhibitor activity;0.0290738219152611;20863,116872,209294,20724!GO:0016298;lipase activity;0.0290738219152611;18784,271844,26971!GO:0030414;protease inhibitor activity;0.0290738219152611;20863,116872,209294,20724!GO:0006643;membrane lipid metabolic process;0.0304293930543865;18784,271844,18705,26971!GO:0001533;cornified envelope;0.0384357979093;68723,14246!GO:0004252;serine-type endopeptidase activity;0.0384357979093;16622,23993,13648,243083!GO:0005884;actin filament;0.0384357979093;72333,14457!GO:0017171;serine hydrolase activity;0.0384357979093;16622,23993,13648,243083!GO:0008236;serine-type peptidase activity;0.0384357979093;16622,23993,13648,243083!GO:0008233;peptidase activity;0.0384357979093;16622,230598,23993,104184,13648,12365,243083!GO:0005856;cytoskeleton;0.0384357979093;16678,72333,66203,16661,68723,14246,14457,24000!GO:0004857;enzyme inhibitor activity;0.0384357979093;20863,116872,209294,20724!GO:0043089;positive regulation of Cdc42 GTPase activity;0.0384357979093;19765!GO:0043088;regulation of Cdc42 GTPase activity;0.0384357979093;19765!GO:0008747;N-acetylneuraminate lyase activity;0.0384357979093;74091!GO:0032489;regulation of Cdc42 protein signal transduction;0.0384357979093;19765!GO:0016919;nardilysin activity;0.0384357979093;230598!GO:0008605;protein kinase CK2 regulator activity;0.0384357979093;13001!GO:0008423;bleomycin hydrolase activity;0.0384357979093;104184!GO:0032488;Cdc42 protein signal transduction;0.0384357979093;19765!GO:0043758;acetate-CoA ligase (ADP-forming) activity;0.0384357979093;14081!GO:0004869;cysteine protease inhibitor activity;0.0384357979093;20863,209294!GO:0044255;cellular lipid metabolic process;0.0395819923507891;18784,271844,18705,107605,26971,14081!GO:0004091;carboxylesterase activity;0.0409526949257572;18784,271844,26971!
|gostat_on_MCL_coexpression=GO:0016042;lipid catabolic process;0.0029286779344968;240633,18784,271844,78753,26971!GO:0004623;phospholipase A2 activity;0.00530930889302839;18784,271844,26971!GO:0016787;hydrolase activity;0.0176780471448425;18784,271844,230598,77042,23993,26971,24000,240633,224079,16622,78753,104184,12365,13648,243083!GO:0004175;endopeptidase activity;0.018306204847719;16622,230598,23993,104184,13648,12365,243083!GO:0006629;lipid metabolic process;0.018306204847719;18784,271844,18705,26971,14081,240633,78753,107605!GO:0004620;phospholipase activity;0.018306204847719;18784,271844,26971!GO:0006508;proteolysis;0.018306204847719;116872,16622,230598,23993,104184,13648,12365,243083!GO:0006644;phospholipid metabolic process;0.018306204847719;18784,271844,18705,26971!GO:0004293;tissue kallikrein activity;0.0290738219152611;16622,13648!GO:0004866;endopeptidase inhibitor activity;0.0290738219152611;20863,116872,209294,20724!GO:0016298;lipase activity;0.0290738219152611;18784,271844,26971!GO:0030414;protease inhibitor activity;0.0290738219152611;20863,116872,209294,20724!GO:0006643;membrane lipid metabolic process;0.0304293930543865;18784,271844,18705,26971!GO:0001533;cornified envelope;0.0384357979093;68723,14246!GO:0004252;serine-type endopeptidase activity;0.0384357979093;16622,23993,13648,243083!GO:0005884;actin filament;0.0384357979093;72333,14457!GO:0017171;serine hydrolase activity;0.0384357979093;16622,23993,13648,243083!GO:0008236;serine-type peptidase activity;0.0384357979093;16622,23993,13648,243083!GO:0008233;peptidase activity;0.0384357979093;16622,230598,23993,104184,13648,12365,243083!GO:0005856;cytoskeleton;0.0384357979093;16678,72333,66203,16661,68723,14246,14457,24000!GO:0004857;enzyme inhibitor activity;0.0384357979093;20863,116872,209294,20724!GO:0043089;positive regulation of Cdc42 GTPase activity;0.0384357979093;19765!GO:0043088;regulation of Cdc42 GTPase activity;0.0384357979093;19765!GO:0008747;N-acetylneuraminate lyase activity;0.0384357979093;74091!GO:0032489;regulation of Cdc42 protein signal transduction;0.0384357979093;19765!GO:0016919;nardilysin activity;0.0384357979093;230598!GO:0008605;protein kinase CK2 regulator activity;0.0384357979093;13001!GO:0008423;bleomycin hydrolase activity;0.0384357979093;104184!GO:0032488;Cdc42 protein signal transduction;0.0384357979093;19765!GO:0043758;acetate-CoA ligase (ADP-forming) activity;0.0384357979093;14081!GO:0004869;cysteine protease inhibitor activity;0.0384357979093;20863,209294!GO:0044255;cellular lipid metabolic process;0.0395819923507891;18784,271844,18705,107605,26971,14081!GO:0004091;carboxylesterase activity;0.0409526949257572;18784,271844,26971!
|ontology_enrichment_celltype=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000014!6.24e-11!5;UBERON:0001003!6.24e-11!5;UBERON:0002097!6.24e-11!5;UBERON:0002199!6.24e-11!5;UBERON:0007029!6.24e-11!5;UBERON:0007376!6.24e-11!5;UBERON:0002416!6.24e-11!5;UBERON:0007383!6.24e-11!5;UBERON:0003102!1.97e-07!22
}}
}}

Revision as of 21:07, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:127196810..127196822,+p1@Rdh1
p4@Rdh9
Mm9::chr10:127196836..127196857,+p2@Rdh9
Mm9::chr10:127196861..127196872,+p6@Rdh9
Mm9::chr10:127335571..127335588,+p1@Sdr9c7
Mm9::chr10:43742088..43742097,-p@chr10:43742088..43742097
-
Mm9::chr10:58114440..58114444,-p@chr10:58114440..58114444
-
Mm9::chr10:7078767..7078772,+p2@H60c
Mm9::chr10:7078798..7078822,+p1@H60c
Mm9::chr10:78175721..78175723,-p@chr10:78175721..78175723
-
Mm9::chr10:78181015..78181049,-p1@Casp14
Mm9::chr10:79243897..79243906,+p@chr10:79243897..79243906
+
Mm9::chr11:103755421..103755464,+p@chr11:103755421..103755464
+
Mm9::chr11:21016871..21016882,+p@chr11:21016871..21016882
+
Mm9::chr11:21016905..21016917,+p@chr11:21016905..21016917
+
Mm9::chr11:46036085..46036096,+p@chr11:46036085..46036096
+
Mm9::chr11:46036133..46036170,+p@chr11:46036133..46036170
+
Mm9::chr11:46040640..46040647,+p@chr11:46040640..46040647
+
Mm9::chr11:60879300..60879318,+p4@Kcnj12
Mm9::chr11:61482530..61482535,+p2@Grap
Mm9::chr11:67346540..67346561,+p16@Gas7
Mm9::chr11:69153950..69153959,+p1@ENSMUST00000129321
Mm9::chr11:76759204..76759215,+p2@Blmh
Mm9::chr11:99247896..99248013,-p@chr11:99247896..99248013
-
Mm9::chr11:99248438..99248449,-p@chr11:99248438..99248449
-
Mm9::chr11:99248629..99248646,-p@chr11:99248629..99248646
-
Mm9::chr11:99248646..99248659,+p1@ENSMUST00000153599
Mm9::chr11:99248948..99248974,-p@chr11:99248948..99248974
-
Mm9::chr11:99249381..99249415,-p@chr11:99249381..99249415
-
Mm9::chr11:99250100..99250167,+p@chr11:99250100..99250167
+
Mm9::chr11:99250286..99250297,+p@chr11:99250286..99250297
+
Mm9::chr11:99250299..99250323,+p@chr11:99250299..99250323
+
Mm9::chr11:99250399..99250443,+p@chr11:99250399..99250443
+
Mm9::chr11:99250665..99250683,-p1@Krt10
Mm9::chr11:99252528..99252534,+p@chr11:99252528..99252534
+
Mm9::chr11:99267149..99267154,-p@chr11:99267149..99267154
-
Mm9::chr12:5498252..5498255,-p@chr12:5498252..5498255
-
Mm9::chr12:99921894..99921903,-p17@Ptpn21
Mm9::chr13:13727206..13727231,+p@chr13:13727206..13727231
+
Mm9::chr13:95064922..95064940,-p3@uc007rlu.1
Mm9::chr13:95064948..95064965,-p2@uc007rlu.1
Mm9::chr13:95064974..95064991,-p1@uc007rlu.1
Mm9::chr14:19542161..19542189,-p@chr14:19542161..19542189
-
Mm9::chr14:19965620..19965628,+p@chr14:19965620..19965628
+
Mm9::chr14:52513307..52513352,+p1@Slc39a2
Mm9::chr15:101676192..101676203,-p@chr15:101676192..101676203
-
Mm9::chr15:101676318..101676330,-p@chr15:101676318..101676330
-
Mm9::chr15:101676364..101676384,-p@chr15:101676364..101676384
-
Mm9::chr15:101676385..101676428,-p@chr15:101676385..101676428
-
Mm9::chr15:101676465..101676477,-p@chr15:101676465..101676477
-
Mm9::chr15:101676705..101676716,-p@chr15:101676705..101676716
-
Mm9::chr15:101677424..101677433,-p@chr15:101677424..101677433
-
Mm9::chr15:101678562..101678591,-p@chr15:101678562..101678591
-
Mm9::chr15:101679480..101679491,-p@chr15:101679480..101679491
-
Mm9::chr15:101679504..101679545,-p@chr15:101679504..101679545
-
Mm9::chr15:101679549..101679563,-p@chr15:101679549..101679563
-
Mm9::chr15:101680772..101680783,+p@chr15:101680772..101680783
+
Mm9::chr15:101681209..101681223,-p1@Krt1
Mm9::chr15:101685184..101685190,+p@chr15:101685184..101685190
+
Mm9::chr15:57817428..57817449,+p1@Fam83a
Mm9::chr15:63640302..63640307,-p3@Gsdmc
Mm9::chr16:25862430..25862438,+p@chr16:25862430..25862438
+
Mm9::chr16:29544938..29544955,-p1@Atp13a4
Mm9::chr16:36131242..36131277,-p2@Csta
Mm9::chr16:36455398..36455417,-p@chr16:36455398..36455417
-
Mm9::chr16:36455464..36455486,-p1@Stfa3
Mm9::chr16:56831873..56831884,-p8@Tmem45a
Mm9::chr16:56831991..56832004,-p5@Tmem45a
Mm9::chr16:65816062..65816086,+p@chr16:65816062..65816086
+
Mm9::chr16:65816092..65816105,+p@chr16:65816092..65816105
+
Mm9::chr16:8737826..8737834,-p@chr16:8737826..8737834
-
Mm9::chr16:89888917..89888924,-p@chr16:89888917..89888924
-
Mm9::chr16:89888952..89888969,-p@chr16:89888952..89888969
-
Mm9::chr17:26116832..26116843,-p@chr17:26116832..26116843
-
Mm9::chr17:26116881..26116895,-p@chr17:26116881..26116895
-
Mm9::chr17:35255480..35255513,-p4@Csnk2b
Mm9::chr17:35255515..35255527,-p12@Csnk2b
Mm9::chr17:35936659..35936666,+p@chr17:35936659..35936666
+
Mm9::chr17:64179284..64179299,+p@chr17:64179284..64179299
+
Mm9::chr17:66234625..66234641,-p2@Ralbp1
Mm9::chr18:57577882..57577889,-p@chr18:57577882..57577889
-
Mm9::chr18:69772289..69772298,+p@chr18:69772289..69772298
+
Mm9::chr19:34082813..34082828,+p1@Lipk
Mm9::chr19:34175495..34175506,+p2@Lipm
Mm9::chr19:3958803..3958832,+p1@1700055N04Rik
Mm9::chr19:47975153..47975185,-p@chr19:47975153..47975185
-
Mm9::chr1:108757794..108757805,+p2@Serpinb5
Mm9::chr1:109296059..109296065,+p3@Serpinb7
Mm9::chr1:109296220..109296242,+p2@Serpinb7
Mm9::chr1:109319258..109319272,+p1@Serpinb7
Mm9::chr1:155396948..155396958,-p4@Npl
Mm9::chr1:155396968..155396985,-p3@Npl
Mm9::chr1:166237331..166237357,-p3@Blzf1
Mm9::chr1:60864776..60864792,+p@chr1:60864776..60864792
+
Mm9::chr1:71461455..71461489,-p1@Abca12
Mm9::chr1:71461496..71461501,-p4@Abca12
Mm9::chr1:71461504..71461515,-p3@Abca12
Mm9::chr2:120139877..120139908,-p1@Pla2g4f
Mm9::chr2:154921736..154921750,+p@chr2:154921736..154921750
+
Mm9::chr2:154921759..154921770,+p@chr2:154921759..154921770
+
Mm9::chr2:154921792..154921799,+p@chr2:154921792..154921799
+
Mm9::chr2:24132429..24132461,+p2@Il1f5
Mm9::chr2:24132783..24132797,+p1@Il1f5
Mm9::chr2:28383308..28383324,+p@chr2:28383308..28383324
+
Mm9::chr2:33302284..33302297,+p1@ENSMUST00000132913
Mm9::chr2:44197282..44197287,+p@chr2:44197282..44197287
+
Mm9::chr2:59617784..59617800,+p7@Tanc1
Mm9::chr3:103893456..103893486,-p@chr3:103893456..103893486
-
Mm9::chr3:148740115..148740124,-p@chr3:148740115..148740124
-
Mm9::chr3:148740200..148740230,-p@chr3:148740200..148740230
-
Mm9::chr3:148997803..148997833,+p@chr3:148997803..148997833
+
Mm9::chr3:37606335..37606337,-p@chr3:37606335..37606337
-
Mm9::chr3:59756107..59756122,+p2@Gm9696
Mm9::chr3:92381042..92381050,-p@chr3:92381042..92381050
-
Mm9::chr3:92425095..92425110,-p1@Lce6a
Mm9::chr3:92425128..92425142,-p2@Lce6a
Mm9::chr3:92425160..92425170,-p4@Lce6a
Mm9::chr3:92524303..92524309,-p2@Lce1f
Mm9::chr3:92674137..92674146,-p1@2310050C09Rik
Mm9::chr3:92822979..92822982,-p1@Lce1m
Mm9::chr3:93077441..93077446,+p1@ENSMUST00000148311
Mm9::chr3:93081466..93081482,+p1@uc008qff.1
Mm9::chr3:93081505..93081513,+p@chr3:93081505..93081513
+
Mm9::chr3:93081561..93081574,+p3@ENSMUST00000122125
Mm9::chr3:93081585..93081601,+p2@ENSMUST00000122125
Mm9::chr3:93083314..93083325,+p@chr3:93083314..93083325
+
Mm9::chr3:93083376..93083436,+p@chr3:93083376..93083436
+
Mm9::chr3:93083448..93083456,+p@chr3:93083448..93083456
+
Mm9::chr3:93083468..93083479,+p@chr3:93083468..93083479
+
Mm9::chr3:93083503..93083529,+p@chr3:93083503..93083529
+
Mm9::chr3:93083530..93083533,+p@chr3:93083530..93083533
+
Mm9::chr3:93083551..93083616,-p@chr3:93083551..93083616
-
Mm9::chr3:93083624..93083665,-p@chr3:93083624..93083665
-
Mm9::chr3:93083628..93083640,+p@chr3:93083628..93083640
+
Mm9::chr3:93083681..93083686,-p@chr3:93083681..93083686
-
Mm9::chr3:93083730..93083744,-p@chr3:93083730..93083744
-
Mm9::chr3:93097001..93097020,+p@chr3:93097001..93097020
+
Mm9::chr3:93097030..93097041,+p@chr3:93097030..93097041
+
Mm9::chr3:93097054..93097069,+p@chr3:93097054..93097069
+
Mm9::chr3:93123662..93123676,+p1@Hrnr
Mm9::chr4:108673414..108673469,+p2@Nrd1
Mm9::chr4:11312573..11312584,-p@chr4:11312573..11312584
-
Mm9::chr4:118241645..118241650,+p@chr4:118241645..118241650
+
Mm9::chr4:138313493..138313521,-p1@Pla2g2f
Mm9::chr4:138362188..138362203,-p@chr4:138362188..138362203
-
Mm9::chr4:148913751..148913768,+p@chr4:148913751..148913768
+
Mm9::chr4:3943619..3943629,-p8@Sdr16c5
Mm9::chr4:3943631..3943644,-p4@Sdr16c5
Mm9::chr4:3946775..3946806,-p2@Sdr16c5
Mm9::chr4:3946815..3946822,-p9@Sdr16c5
Mm9::chr4:4039403..4039426,-p@chr4:4039403..4039426
-
Mm9::chr4:48911430..48911437,+p1@ENSMUST00000131099
Mm9::chr4:56237392..56237416,-p1@ENSMUST00000128591
p1@uc008sxm.1
Mm9::chr5:103289117..103289139,+p@chr5:103289117..103289139
+
Mm9::chr5:22909104..22909126,-p@chr5:22909104..22909126
-
Mm9::chr5:87020458..87020497,-p@chr5:87020458..87020497
-
Mm9::chr5:91831931..91831948,-p1@Btc
Mm9::chr6:128884391..128884405,+p1@Clec2g
Mm9::chr6:128910615..128910618,+p@chr6:128910615..128910618
+
Mm9::chr6:139547998..139548022,+p2@Pik3c2g
Mm9::chr6:141726608..141726619,-p@chr6:141726608..141726619
-
Mm9::chr6:141726622..141726645,-p@chr6:141726622..141726645
-
Mm9::chr6:24698325..24698356,+p1@Hyal4
Mm9::chr6:54942852..54942872,-p1@Ggct
Mm9::chr7:114825193..114825205,+p@chr7:114825193..114825205
+
Mm9::chr7:31537176..31537209,-p@chr7:31537176..31537209
-
Mm9::chr7:31548769..31548784,+p1@Dmkn
Mm9::chr7:31549808..31549821,+p@chr7:31549808..31549821
+
Mm9::chr7:31551592..31551595,+p@chr7:31551592..31551595
+
Mm9::chr7:4432380..4432391,+p@chr7:4432380..4432391
+
Mm9::chr7:51047311..51047319,+p2@Klk9
Mm9::chr7:51066691..51066694,+p2@Klk7
Mm9::chr7:51097277..51097288,+p4@Klk5
Mm9::chr7:51097301..51097320,+p1@Klk5
Mm9::chr7:51097362..51097373,+p6@Klk5
Mm9::chr7:51097601..51097633,+p2@Klk5
Mm9::chr7:51097635..51097675,+p3@Klk5
Mm9::chr7:51102425..51102448,+p@chr7:51102425..51102448
+
Mm9::chr7:52810362..52810377,+p@chr7:52810362..52810377
+
Mm9::chr7:81365065..81365070,+p@chr7:81365065..81365070
+
Mm9::chr7:91838458..91838474,-p4@Zfand6
Mm9::chr8:127138081..127138119,+p@chr8:127138081..127138119
+
Mm9::chr8:26416675..26416689,-p2@5430421F17Rik
Mm9::chr8:26416693..26416711,-p1@5430421F17Rik
Mm9::chr8:47576298..47576305,+p13@Acsl1
Mm9::chr8:64239216..64239219,-p12@Palld
Mm9::chr9:100386881..100386911,-p1@Il20rb
Mm9::chr9:106584501..106584516,-p@chr9:106584501..106584516
-
Mm9::chr9:121276138..121276160,+p3@Trak1
Mm9::chr9:70360014..70360027,+p@chr9:70360014..70360027
+
Mm9::chr9:70360031..70360051,+p@chr9:70360031..70360051
+
Mm9::chr9:70374687..70374699,+p@chr9:70374687..70374699
+
Mm9::chrX:108564271..108564282,-p@chrX:108564271..108564282
-
Mm9::chrX:156278395..156278404,+p22@Sh3kbp1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0016042lipid catabolic process0.0029286779344968
GO:0004623phospholipase A2 activity0.00530930889302839
GO:0016787hydrolase activity0.0176780471448425
GO:0004175endopeptidase activity0.018306204847719
GO:0006629lipid metabolic process0.018306204847719
GO:0004620phospholipase activity0.018306204847719
GO:0006508proteolysis0.018306204847719
GO:0006644phospholipid metabolic process0.018306204847719
GO:0004293tissue kallikrein activity0.0290738219152611
GO:0004866endopeptidase inhibitor activity0.0290738219152611
GO:0016298lipase activity0.0290738219152611
GO:0030414protease inhibitor activity0.0290738219152611
GO:0006643membrane lipid metabolic process0.0304293930543865
GO:0001533cornified envelope0.0384357979093
GO:0004252serine-type endopeptidase activity0.0384357979093
GO:0005884actin filament0.0384357979093
GO:0017171serine hydrolase activity0.0384357979093
GO:0008236serine-type peptidase activity0.0384357979093
GO:0008233peptidase activity0.0384357979093
GO:0005856cytoskeleton0.0384357979093
GO:0004857enzyme inhibitor activity0.0384357979093
GO:0043089positive regulation of Cdc42 GTPase activity0.0384357979093
GO:0043088regulation of Cdc42 GTPase activity0.0384357979093
GO:0008747N-acetylneuraminate lyase activity0.0384357979093
GO:0032489regulation of Cdc42 protein signal transduction0.0384357979093
GO:0016919nardilysin activity0.0384357979093
GO:0008605protein kinase CK2 regulator activity0.0384357979093
GO:0008423bleomycin hydrolase activity0.0384357979093
GO:0032488Cdc42 protein signal transduction0.0384357979093
GO:0043758acetate-CoA ligase (ADP-forming) activity0.0384357979093
GO:0004869cysteine protease inhibitor activity0.0384357979093
GO:0044255cellular lipid metabolic process0.0395819923507891
GO:0004091carboxylesterase activity0.0409526949257572



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
zone of skin6.24e-115
skin epidermis6.24e-115
skin of body6.24e-115
integument6.24e-115
surface6.24e-115
outer epithelium6.24e-115
integumental system6.24e-115
enveloping layer of ectoderm6.24e-115
surface structure1.97e-0722


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:71&oldid=2156513"